🇺🇸 Decortin in United States
1,306 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 1,306
Most-reported reactions
- Nausea — 176 reports (13.48%)
- Pyrexia — 163 reports (12.48%)
- Toxic Epidermal Necrolysis — 160 reports (12.25%)
- Diarrhoea — 150 reports (11.49%)
- Pneumonia — 136 reports (10.41%)
- General Physical Health Deterioration — 133 reports (10.18%)
- Dyspnoea — 121 reports (9.26%)
- Dizziness — 90 reports (6.89%)
- Fatigue — 89 reports (6.81%)
- Urinary Tract Infection — 88 reports (6.74%)
Other Other approved in United States
Frequently asked questions
Is Decortin approved in United States?
Decortin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Decortin in United States?
STZ eyetrial is the originator. The local marketing authorisation holder may differ — check the official source linked above.